The Atrial Fibrillation Market is expected to be around US$ 13.65 Billion by 2028 at a CAGR of 13.8% in the given forecast period.
Rising prevalence of atrial fibrillation in geriatric populace, innovative progressions, and increment in the inclination of catheter removal for cardiovascular arrhythmia treatment drive the surge of atrial fibrillation Market.
The growth in number of individuals experiencing hypertension and heart illnesses are a portion of the normal dangers which are advancing the requirement for better treatment.
The global Atrial Fibrillation Market is segregated on the basis of Application as Diagnostic, Surgical, EP Ablation, and Others. Based on Product the global Atrial Fibrillation Market is segmented in EP Diagnostic Catheter, EP Ablation Catheters, Left Atrial Appendage Closure Devices, Cardiac Monitors or Implantable Loop Recorder, Mapping and Recording Systems, Access Devices, and Intracardiac Echocardiography. Based on End-User Industry the global Atrial Fibrillation Market is segmented in Cardiac Centers, Ambulatory Surgical Centers, and Hospitals.
The global Atrial Fibrillation Market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Atrial Fibrillation Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
SIEMENS AG, KONINKLIJKE PHILIPS N.V., BIOTRONIK SE & CO. KG, JOHNSON & JOHNSON, ATRICURE, INC., MICROPORT SCIENTIFIC CORPORATION, BOSTON SCIENTIFIC CORPORATION, ABBOTT LABORATORIES, MEDTRONIC PLC, JUDE MEDICAL, INC., and others are among the major players in the global Atrial Fibrillation Market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Atrial Fibrillation Market has been segmented as below:
Atrial Fibrillation Market, By Application
Atrial Fibrillation Market, By Product
Atrial Fibrillation Market, By End-User Industry
Atrial Fibrillation Market, By Region
Atrial Fibrillation Market, By Company
The report covers:
Report Scope:
The global Atrial Fibrillation Market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level Market dynamics. The scope also covers competitive overview providing company Market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering Market shares and profiles key participants in the global Atrial Fibrillation Market share. Major industry players with significant revenue share include SIEMENS AG, KONINKLIJKE PHILIPS N.V., BIOTRONIK SE & CO. KG, JOHNSON & JOHNSON, ATRICURE, INC., MICROPORT SCIENTIFIC CORPORATION, BOSTON SCIENTIFIC CORPORATION, ABBOTT LABORATORIES, MEDTRONIC PLC, JUDE MEDICAL, INC., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Ocular Inflammation Treatment Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Atrial Fibrillation Market, By Application
5.1 Introduction
5.2 Diagnostic
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Surgical
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 EP Ablation
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Others
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Atrial Fibrillation Market, By Product
6.1 Introduction
6.2 EP Diagnostic Catheter
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 EP Ablation Catheters
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Left Atrial Appendage Closure Devices
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Cardiac Monitors or Implantable Loop Recorder
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Mapping and Recording Systems
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Access Devices
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Intracardiac Echocardiography
6.8.1 Market Overview
6.8.2 Market Size and Forecast
7. Atrial Fibrillation Market, By End-User Industry
7.1 Introduction
7.2 Cardiac Centers
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Ambulatory Surgical Centers
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Hospitals
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8. Atrial Fibrillation Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Atrial Fibrillation, By Application
8.2.2 North America Atrial Fibrillation, By Product
8.2.3 North America Atrial Fibrillation, By End-User Industry
8.3 Europe
8.3.1 Europe Atrial Fibrillation, By Application
8.3.2 Europe Atrial Fibrillation, By Product
8.3.3 Europe Atrial Fibrillation, By End-User Industry
8.4 Asia-Pacific
8.4.1 Asia-Pacific Atrial Fibrillation, By Application
8.4.2 Asia-Pacific Atrial Fibrillation, By Product
8.4.3 Asia-Pacific Atrial Fibrillation, By End-User Industry
8.5 Rest of the World
8.5.1 Rest of the World Atrial Fibrillation, By Application
8.5.2 Rest of the World Atrial Fibrillation, By Product
8.5.3 Rest of the World Atrial Fibrillation, By End-User Industry
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 SIEMENS AG
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 KONINKLIJKE PHILIPS N.V.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 BIOTRONIK SE & CO. KG
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 JOHNSON & JOHNSON
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 ATRICURE, INC.
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 MICROPORT SCIENTIFIC CORPORATION
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 BOSTON SCIENTIFIC CORPORATION
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 ABBOTT LABORATORIES
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 MEDTRONIC PLC
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 JUDE MEDICAL, INC.
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Atrial Fibrillation Market has been segmented as below:
Atrial Fibrillation Market, By Application
Atrial Fibrillation Market, By Product
Atrial Fibrillation Market, By End-User Industry
Atrial Fibrillation Market, By Region
Atrial Fibrillation Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
